Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
799 people get SIGA articles and Market Currents by email alert.
Get email alerts on SIGA »
FOCUS
|
PRO
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
Stock Watch: SIGA Opens The Week With A BangVFC's Stock House • Tue, Mar 27, 2012 -
-
SIGA's Short-Term Move Belies Long-Term PotentialVFC's Stock House • Tue, Mar 6, 2012
-
-
-
-
Siga Seeks Another Lawsuit LookVFC's Stock House • Sun, Oct 9, 2011
-
-
SIGA Shares Could Fly on BARDA ContractVFC's Stock House • Tue, Jun 28, 2011
-
-
-
-
-
-
-
-
-
-
To learn more about Seeking Alpha Pro, click here.
-
-
-
-
-
-
-
-
-
3 Liquid And Profitable Biotech StocksZetaKap • Mon, Aug 6, 2012 -
6 Highly Profitable Healthcare Stocks With Plenty Of CashZetaKap • Fri, Aug 3, 2012
-
-
-
5 Analyst-Backed Healthcare Stocks Raking In ProfitsZetaKap • Tue, Jul 3, 2012
-
-
Weekly Stock Watch: Week Of June 18VFC's Stock House • Sun, Jun 17, 2012
-
-
Weekly Stock Watch: Week Of June 4, 2012VFC's Stock House • Mon, Jun 4, 2012
-
-
-
-
SIGA Technologies, Inc., Q2 2012 Guidance/Update Call, Aug 06, 2012Mon, Aug 6, 2012
-
SIGA Technologies Q2 2007 Earnings Call TranscriptFri, Aug 17, 2007
-
GlobeNewswire (May 29, 2013)
-
GlobeNewswire (May 15, 2013)
-
GlobeNewswire (Apr 30, 2013)
-
GlobeNewswire (Mar 12, 2013)
-
GlobeNewswire (Mar 6, 2013)
-
GlobeNewswire (Mar 1, 2013)
-
GlobeNewswire (Nov 29, 2012)
-
GlobeNewswire (Nov 5, 2012)
-
GlobeNewswire (Oct 29, 2012)
-
GlobeNewswire (Aug 6, 2012)
-
GlobeNewswire (Jul 30, 2012)
-
PR Newswire (Jun 12, 2012)
-
GlobeNewswire (Jun 4, 2012)
-
GlobeNewswire (Jun 1, 2012)
-
GlobeNewswire (May 7, 2012)
-
GlobeNewswire (Apr 30, 2012)
-
GlobeNewswire (Dec 16, 2011)
-
at CNBC.com (Jun 17, 2011)
SIGA vs. ETF Alternatives
Company Description
SIGA is a biotechnology corporation incorporated in Delaware on December 28, 1995. We pursue the research, development and commercialization of novel anti-infectives for the prevention and treatment of serious infectious diseases. The major focus of our developmental and commercialization... More
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Thursday, May 30, 9:42 AM It looks like PharmAthene (PIP +7.7%) investors will be in for another roller coaster of a session as the stock jumps out of the gate after the FDA lifts its clinical hold on the company's SparVax vaccine program. (Recently: PIP/SIGA claim legal victory) (PR) Comment! [Healthcare, On the Move]
- Wednesday, May 29, 10:59 AM Investors who took a "glass is half full" approach regarding shares of both PharmAthene (PIP -11.3%) and SIGA Technologies (SIGA -0.3%) Tuesday after each company essentially claimed it came out ahead in a recent court ruling, are changing course today, as both companies trade lower, with PIP off double-digits. See SA contributor G. Hudon's recent article (and comments section) for more. Comment! [On the Move]
- Tuesday, May 28, 9:14 AM Premarket gainers: CSIQ +25%. PIP +21%. ROYL +17%. BGMD +11%. BLDP +11%. VRX +11%. SIGA +8%. TSL +8%. MAKO +8%. YGE +8%. CPST +8%. STSI +8%. HSOL +7%. ALU +7%. LDK +7%. JASO +7%. TIF +6%. Comment! [On the Move]
- Tuesday, May 28, 8:28 AM PharmAthene (PIP) soars 28% premarket after the Delaware Supreme Court upholds an earlier ruling against SIGA Technologies (SIGA) for breach of contractual obligation. In related news: SIGA jumps 10% premarket on the same court ruling as the company notes the court reversed an "equitable payment stream" decision. SIGA also says it intends to establish in Chancery Court "that PIP's evidence of expectancy damages is too speculative, contingent, and conjectural to permit an award." (previous) Comment! [Healthcare, On the Move]
-
Friday, May 24, 5:42 PM
After-hours top gainers, as of 5:15 p.m.: SIGA +23%. FXEN +7%. LPSN +5%. QSII +4%. STRZA +3%.
After-hours top losers: XNPT -7%. DF -6%. ASTX -4%. SPWR -3%. FNSR -2%. Comment! [On the Move] - Wednesday, March 6, 4:55 PM SIGA Technologies (SIGA): Q4 EPS of -$0.06 misses by $0.13. Revenue of $2.5M misses by $3.5M. (PR) Comment! [Earnings, Breaking News, Healthcare]
- Friday, November 30, 2012, 3:18 PM SIGA Technologies (SIGA +4.7%) is up strongly after announcing it has received a $12.3M milestone payment from the U.S. government related to a national stockpile contract for its smallpox drug. The company also announced the drug, formerly known as ST-246, will now be called Arestvyr. The stockpile contract has been a source of controversy. Comment! [Healthcare, On the Move]
- Friday, June 1, 2012, 10:36 AM PharmAthene (PIP +37%) soars today, after a U.S. court upheld a ruling awarding it a portion of profits received by Siga Technologies (SIGA -2.6%) from its smallpox antiviral drug, ST-246. The decision is just the latest development in what has turned out to be a long-running legal battle between the two companies. Comment! [On the Move, Healthcare]
- Friday, December 9, 2011, 3:19 PM Siga Technologies (SIGA +29%) rallies a day after a board member responds to allegations of unfair practices in the awarding of a multi-billion dollar government contract to the pharmaceutical company, saying the contract was given in a competitive process but its rival did not meet the requirements at the time of the contract award. Comment! [Healthcare, On the Move]
- Monday, November 14, 2011, 1:42 PM Another Solyndra? LA Times reports the Obama administration has been pushing a $433M plan to buy Siga Technologies' (SIGA -9.1%) experimental smallpox drug, despite uncertainty over whether it is needed or will work at all. Siga, whose controlling shareholder is top Obama donor Ronald Perelman, was awarded a contract in May in a no-bid deal after the government's lead negotiator was replaced. 17 Comments [Healthcare, On the Move]
-
Friday, September 23, 2011, 9:00 AM
Premarket gainers: SIGA +15%. NKE +5%. CTIC +4%. YOKU +3%.
Losers: FRO -7%. NBG -7%. CEF -6%. SLW -6%. ING -5%. MDW -4%. BBVA -4%. AUY -4%. MOS -4%. HL -4%. VE -4%. TOT -3%. ABX -3%. SDRL -3%. SAP -3%. ARMH -3%. TSM -3%. Comment! [On the Move] - Thursday, September 22, 2011, 6:20 PM Shares of SIGA Technologies (SIGA) were hammered -43% during the afternoon session today, after a Delaware court ruled in favor of PharmAthene (PIP) in a dispute involving SIGA's smallpox drug ST-246. Under the ruling, SIGA can keep the first $40M in net profit from sales of the drug, after which it must then hand over 50% of the net profits to PharmAthene for the next ten years. 2 Comments [Healthcare, On the Move]
- Thursday, September 22, 2011, 2:17 PM PharmAthene (PIP +21%) soars after a Delaware court rules that Siga Technologies (SIGA -0.4%) must share profits from the sales of its smallpox drug that could total over $400M. 2 Comments [Healthcare, On the Move]
- Wednesday, August 24, 2011, 4:41 PM SIGA Technologies (SIGA) closed with a +7.3% gain after the company says it's been awarded a $7.7M grant from the NIH to develop an antiviral drug to treat a variety of hemorrhagic fevers. Comment! [Healthcare, On the Move]
- Tuesday, June 28, 2011, 9:08 AM SIGA Technologies (SIGA) +5.2% after announcing that it will sell 1.7M courses of its smallpox antiviral ST-246 to the U.S. national stockpile, after a protest filed against the contract is withdrawn following execution of a contract modification. Comment! [Healthcare, On the Move]
-
Tuesday, June 28, 2011, 9:00 AM
Premarket gainers: YOKU +7%. SIGA +6%. ACN +6%. LNKD +6%. IRE +5%. NKE +5%. NBG +4%. SPRD +3%. ALU +3%. RENN +3%.
Losers: CEL -5%. EEP -4%. GRMN -3%. NGD -3%. SI -3%. 1 Comment [On the Move]
-
Larry Monkelban
$SIGA Judge sets aside previous ruling on damage stemming from lawsuit over potential windfall...up up and away - View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
- View all 3 replies
-
-
LATEST REPLIES
-
- View all 3 replies
-
-